Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Documenti analoghi

• Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
  di: Cornely, Oliver A., et al.
  Pubblicazione: (2016)
• Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
  di: Duarte, Rafael F., et al.
  Pubblicazione: (2014)
• A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole
  di: van Iersel, Marlou L. P. S., et al.
  Pubblicazione: (2018)
• Effect of a High-Fat Meal on the Pharmacokinetics of 300-Milligram Posaconazole in a Solid Oral Tablet Formulation
  di: Kersemaekers, Wendy M., et al.
  Pubblicazione: (2015)
• Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
  di: Kraft, Walter K., et al.
  Pubblicazione: (2014)